Gliknik

Discovering and developing innovative biologics for immune disorders and cancers

placeBaltimore, Maryland, United States calendar_todayFounded 2007 groups6 employees language gliknik.com

Registered entities

Investor mix

8 investors on record; lead investors include Brace Pharma Capital, Pfizer, First In Ventures.

Investor typeCountShare
Venture capital563%
Private equity113%
Other / undisclosed225%
Coming soon